Protalix BioTherapeutics, Inc. (DE) (PLX) SEC filings
PLX SEC filings moved a median of -1.25% by the close. PLX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PLX overview →
54 measured PLX SEC filing events.
Where these PLX SEC filings landedvs 52 measured PLX SEC filing reactions
| Middle 50% of PLX SEC filing reactions | -2.95% to +4.79% |
|---|---|
| Median reaction (to close) | -1.25% |
| Measured reactions | 52 |
Point-in-time · zero look-ahead
Half of the 52 PLX SEC filing events with a measured close landed between -2.95% and +4.79%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Protalix BioTherapeutics For: Jun 30 | SEC filing · Form 10-Q | -1.21% | +5.22% | |
| Form 8-K Protalix BioTherapeutics For: Aug 12 | SEC filing · Form 8-K | -1.21% | +5.22% | |
| Form S-8 Protalix BioTherapeutics | SEC filing · Form S-8 | -1.21% | +5.22% | |
| Form 8-K Protalix BioTherapeutics For: Jun 25 | SEC filing · Form 8-K | -0.23% | +3.60% | |
| Form 8-K Protalix BioTherapeutics For: May 21 | SEC filing · Form 8-K | +0.51% | +2.52% | |
| Form 10-Q Protalix BioTherapeutics For: Mar 31 | SEC filing · Form 10-Q | +7.11% | -2.03% | |
| Form 8-K Protalix BioTherapeutics For: May 13 | SEC filing · Form 8-K | +7.11% | -2.03% | |
| Form ARS Protalix BioTherapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -1.85% | |
| Form DEF 14A Protalix BioTherapeutics For: Jun 25 | SEC filing · Form DEF | +0.00% | -1.85% | |
| Form 10-K Protalix BioTherapeutics For: Dec 31 | SEC filing · Form 10-K | -7.49% | -3.07% | |
| Form 8-K Protalix BioTherapeutics For: Mar 18 | SEC filing · Form 8-K | -7.49% | -3.07% | |
| Form 8-K Protalix BioTherapeutics For: Mar 09 | SEC filing · Form 8-K | +3.77% | +8.68% | |
| Form 8-K Protalix BioTherapeutics For: Feb 11 | SEC filing · Form 8-K | +0.34% | -2.39% | |
| Form 8-K Protalix BioTherapeutics For: Jan 30 | SEC filing · Form 8-K | +0.02% | +3.79% | |
| Form 8-K Protalix BioTherapeutics For: Jan 05 | SEC filing · Form 8-K | +2.30% | +2.87% | |
| Form 10-Q Protalix BioTherapeutics For: Sep 30 | SEC filing · Form 10-Q | +6.52% | — | |
| Form 8-K Protalix BioTherapeutics For: Nov 13 | SEC filing · Form 8-K | +6.52% | — | |
| Form 8-K Protalix BioTherapeutics For: Nov 03 | SEC filing · Form 8-K | -0.87% | +1.30% | |
| Form 8-K Protalix BioTherapeutics For: Oct 17 | SEC filing · Form 8-K | -2.68% | +10.71% | |
| Form EFFECT Protalix BioTherapeutics | SEC filing · Form EFFECT | +0.30% | -2.44% | |
| Form 8-K Protalix BioTherapeutics For: Aug 22 | SEC filing · Form 8-K | +0.30% | -2.44% | |
| Form 10-Q Protalix BioTherapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.56% | |
| Form 8-K Protalix BioTherapeutics For: Aug 14 | SEC filing · Form 8-K | +0.00% | -2.56% | |
| Form S-3/A Protalix BioTherapeutics | SEC filing · Form S-3 | +0.00% | -2.56% | |
| Form 8-K Protalix BioTherapeutics For: Aug 01 | SEC filing · Form 8-K | -0.68% | +2.04% | |
| Form 8-K Protalix BioTherapeutics For: Jun 13 | SEC filing · Form 8-K | -0.33% | -0.65% | |
| Form 8-K Protalix BioTherapeutics For: Jun 26 | SEC filing · Form 8-K | -2.05% | +4.76% | |
| Form 10-Q Protalix BioTherapeutics For: Mar 31 | SEC filing · Form 10-Q | -17.99% | -28.03% | |
| Form 8-K Protalix BioTherapeutics For: May 09 | SEC filing · Form 8-K | -17.99% | -28.03% | |
| Form ARS Protalix BioTherapeutics For: Dec 31 | SEC filing · Form ARS | -17.99% | -28.03% | |
| Form DEF 14A Protalix BioTherapeutics For: Jun 26 | SEC filing · Form DEF | -3.88% | -2.91% | |
| Form S-3 Protalix BioTherapeutics | SEC filing · Form S-3 | +1.40% | +3.50% | |
| Form 8-K Protalix BioTherapeutics For: Apr 21 | SEC filing · Form 8-K | -1.67% | -2.00% | |
| Form 10-K Protalix BioTherapeutics For: Dec 31 | SEC filing · Form 10-K | +10.97% | +3.38% | |
| Form 8-K Protalix BioTherapeutics For: Mar 17 | SEC filing · Form 8-K | +10.97% | +3.38% | |
| Form 8-K Protalix BioTherapeutics For: Dec 27 | SEC filing · Form 8-K | +1.07% | +5.91% | |
| Form 8-K Protalix BioTherapeutics For: Dec 23 | SEC filing · Form 8-K | +1.72% | -0.57% | |
| Form 10-Q Protalix BioTherapeutics For: Sep 30 | SEC filing · Form 10-Q | +3.17% | +11.90% | |
| Form 8-K Protalix BioTherapeutics For: Nov 14 | SEC filing · Form 8-K | +3.17% | +11.90% | |
| Form 8-K Protalix BioTherapeutics For: Oct 25 | SEC filing · Form 8-K | +3.85% | +4.85% | |
| Form 10-Q Protalix BioTherapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -10.58% | |
| Form 8-K Protalix BioTherapeutics For: Aug 14 | SEC filing · Form 8-K | +0.00% | -10.58% | |
| Form S-8 Protalix BioTherapeutics | SEC filing · Form S-8 | +1.74% | -2.61% | |
| Form 8-K Protalix BioTherapeutics For: Jun 27 | SEC filing · Form 8-K | +0.00% | -10.00% | |
| Form ARS Protalix BioTherapeutics For: Dec 31 | SEC filing · Form ARS | -0.70% | +5.26% | |
| Form DEFA14A Protalix BioTherapeutics | SEC filing · Form DEFA14A | -0.70% | +5.26% | |
| Form 10-Q Protalix BioTherapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.96% | +5.77% | |
| Form 8-K Protalix BioTherapeutics For: May 10 | SEC filing · Form 8-K | +0.96% | +5.77% | |
| Form DEF 14A Protalix BioTherapeutics For: Jun 27 | SEC filing · Form DEF | -1.67% | -5.00% | |
| Form 10-K Protalix BioTherapeutics For: Dec 31 | SEC filing · Form 10-K | -7.62% | -11.04% | |
| Form 8-K Protalix BioTherapeutics For: Mar 14 | SEC filing · Form 8-K | -7.62% | -11.04% | |
| Form 8-K Protalix BioTherapeutics For: Dec 26 | SEC filing · Form 8-K | +2.21% | +1.66% | |
| Form 10-Q Protalix BioTherapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.59% | -10.12% | |
| Form 8-K Protalix BioTherapeutics For: Nov 06 | SEC filing · Form 8-K | -0.59% | -10.12% |
Keep exploring
More PLX: earnings → · analyst actions → · PLX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
| Inogen, Inc (INGN) | 197 | +0.31% | 60% |
| AC Immune SA (ACIU) | 195 | -0.43% | 42% |
| Stereotaxis, Inc. (STXS) | 195 | +0.23% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.